Clinical Value of Combined Determination of Serum B7-H4 with Carcinoembryonic Antigen, Osteopontin, or Tissue Polypeptide-Specific Antigen for the Diagnosis of Colorectal Cancer

<div>The diagnosis value of serum B7-H4/OPN/TPS/CEA in CRC patients. Combined analysis using B7-H4 and CEA revealed sensitivity of 98.9% and specificity of 80.4% for discriminating CRC patients from healthy controls.</div>

Disease Markers

fig2

Figure 2

Figure 2: Clinical Value of Combined Determination of Serum B7-H4 with Carcinoembryonic Antigen, Osteopontin, or Tissue Polypeptide-Specific Antigen for the Diagnosis of Colorectal Cancer 

Figure 2 | Clinical Value of Combined Determination of Serum B7-H4 with Carcinoembryonic Antigen, Osteopontin, or Tissue Polypeptide-Specific Antigen for the Diagnosis of Colorectal Cancer 